TRPC7: A promising drug target and biomarker for pain perception and neuropathic pain

Target Name: TRPC7

NCBI ID: G57113

TRPC7

Other Name(s): Short transient receptor potential channel 7 (isoform 2) | TRP7 | TrpC7 | putative capacitative calcium channel | Short transient receptor potential channel 7 | transient receptor potential cation channel subfamily C member 7 | Likley ortholog of mouse transient receptor potential cation channel, subfamily C, member 7 | Transient receptor protein 7 | Short transient receptor potential channel 7 (isoform 1) | Transient receptor potential cation channel subfamily C member 7, transcript variant 1 | Transient receptor potential cation channel, subfamily C, member 7 | hTRP7 | TRP-7 | Putative capacitative calcium channel | TRPC7 variant 1 | TRPC7_HUMAN | likley ortholog of mouse transient receptor potential cation channel, subfamily C, member 7 | transient receptor protein 7 | Transient receptor potential cation channel subfamily C member 7, transcript variant 2 | TRPC7 variant 2

TRPC7: A promising drug target and biomarker for pain perception and neuropathic pain

Abstract:

Transient receptor potential channels (TRPCs) are involved in pain perception and neuropathic pain. TRPC7 is one of the TRPCs that has been well-studied, and its role in pain perception and neuropathic pain has been demonstrated. As a result, TRPC7 can be considered as a drug target and biomarker for pain perception and neuropathic pain. This article will discuss the structure of TRPC7, its role in pain perception, neuropathic pain, and its potential as a drug target and biomarker.

Introduction:

Neuropathic pain is a type of pain that is caused by a disruption in the normal neural communication. This type of pain is often difficult to manage and can cause significant morbidity and disability. The TRPCs, a family of transmembrane ion channels, play a crucial role in pain perception and neuropathic pain. TRPCs are involved in the transduction of pain signals from the peripheral nervous system to the central nervous system. Of the TRPCs, TRPC7 is one of the most well-studied and has the potential to be a drug target and biomarker for pain perception and neuropathic pain.

Structure of TRPC7:

TRPC7 is a member of the TRPC family and is expressed in various tissues, including brain, spinal cord, and peripheral nerves. It is a single-channel TRPC that is characterized by its voltage-dependent opening and closing. TRPC7 has a unique molecular mechanism of action, as it is regulated by the endogenous ligand, natriuretic peptide YQ (NPYQ), which is a neurotransmitter that is involved in vasodilation and blood pressure regulation.

Role of TRPC7 in pain perception and neuropathic pain:

TRPC7 is involved in pain perception and neuropathic pain. It is a critical channel for the transduction of pain signals from the peripheral nervous system to the central nervous system. TRPC7 is activated by changes in membrane potential, which are caused by the activation of its endogenous ligand, NPYQ. When NPYQ binds to TRPC7, it causes a change in the membrane potential, leading to the activation of TRPC7 and the transduction of pain signals.

TRPC7 has also been shown to be involved in neuropathic pain. Neuropathic pain is often characterized by chronic pain that is caused by a disruption in the normal neural communication. TRPC7 has also been shown to be involved in the modulation of pain in neuropathic pain. For example , TRPC7 has been shown to be involved in the modulation of pain in neuropathic pain-related neuroinflammation.

Potential as a drug target:

TRPC7 has the potential to be a drug target for pain perception and neuropathic pain. Its role in pain perception and neuropathic pain can make it an attractive target for small molecule inhibitors. TRPC7 is a fast-acting channel, which means that small molecule inhibitors can have a rapid and lasting effect on its function. Additionally, TRPC7 is a good candidate for a drug because it has a high protein expression level and a low potential for off-target effects.

TRPC7 has also been shown to be involved in the modulation of pain in neuropathic pain. Its involvement in this process makes it a potential target for small molecule inhibitors. -related neuroinflammation. Therefore, inhibitors of TRPC7 could be a promising approach

Protein Name: Transient Receptor Potential Cation Channel Subfamily C Member 7

Functions: Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Activated by diacylglycerol (DAG) (By similarity). May also be activated by intracellular calcium store depletion

The "TRPC7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRPC7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets